A Phase 4 interventional study of cefdinir (Omnicef) and azithromycin in Healthy, sponsored by Abbott. Completed at 3 sites in United States. Open to participants aged 4 Years to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-03-27.
Sponsored by Abbott · Phase 4 and Interventional
To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication.
The Primary Purpose for the study is "Other". Per ClinicalTrias.gov, more information regarding the primary purpose is described here; this study is a pediatric taste test.
Abbott is the lead sponsor of 350 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: cefdinir (Omnicef)
Drug: azithromycin
2.5 ml of strawberry cream flavored oral suspension 125 mg/5 ml
Also known as: ABT-198, Omnicef, cefdinir
2.5 ml of cherry flavored oral suspension 100 mg/5 ml
Also known as: Zithromax
Taste and smell acceptance and preference
Time frame: 2 hours
Adverse events assessment
Time frame: 72 hours with follow-up to a satisfactory conclusion
Concomitant Medications
Time frame: 72 hours
Vital signs
Time frame: 2 hours
Any clinically abnormal observations
Time frame: 2 hours with follow-up to a satisfactory conclusion
This study is completed, as verified in Mar 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Abbott